Are CAR T-cell treatments likely to become available for acute myeloid leukemia?

Gail J. Roboz, USA

During Blood Cancer Awareness Month, Know AML spoke to Gail Roboz, a world-leading doctor in acute myeloid leukemia. We asked, "Is there any prospect of CAR T-cell immunotherapy treatments becoming available for acute myeloid leukemia?" In this video, Gail describes how CAR T-cells have proved to be a promising modality for other hematological malignancies, before describing their use in clinical trials in acute myeloid leukemia and the results so far.